SGMO
Sangamo Therapeutics Sees Significant Pipeline Progress Amid Regulatory and Market Uncertainty
Sangamo Therapeutics, a company at the forefront of gene therapy and genomic medicine development, has made significant strides in its pipeline progress despite regulatory and market uncertainty. In its Q4 2025 conference call, the company's executives highlighted several key achievements that underscore its commitment to helping patients in